Results 31 to 40 of about 1,905,672 (358)

Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence [PDF]

Cancer, 2010
AbstractBACKGROUND:Postprostatectomy adjuvant or salvage radiotherapy, when using standard fractionation, requires 6.5 to 8 weeks of treatment. The authors report on the safety and efficacy of an expedited radiotherapy course for salvage prostate radiotherapy.METHODS:A total of 108 consecutive patients were treated with salvage radiation therapy to 65 ...
Tim J, Kruser, David F, Jarrard, Andrew K, Graf, Sean P, Hedican, David R, Paolone, John D, Wegenke, Glenn, Liu, Heather M, Geye, Mark A, Ritter   +8 more
openaire   +2 more sources

Effect of Salvage Radiotherapy and Endocrine Therapy on Patients with Biochemical Recurrence After Prostate Cancer Operation— a Meta‑Analysis

American Journal of Men's Health, 2021
Context: Several studies reported the application of androgen deprivation therapy and radiotherapy in patients with biochemical recurrence after prostate cancer operation.
Yong Yuan MD, Qiang Zhang MD, Chaofan Xie MD, Tao Wu MD, PhD   +3 more
doaj   +1 more source

18F-fluciclovine (Axumin) PET/CT detecting occult bone metastasis

The Egyptian Journal of Radiology and Nuclear Medicine, 2020
Background 18F-fluciclovine (Axumin) positron emission tomography (PET) is a novel agent for detection of biochemical recurrence of the prostate cancer.
Pankaj Nepal, Paul Rodrigue, Thomas Olsavsky   +2 more
doaj   +1 more source

Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.

European Urology, 2019
CONTEXT In men with prostate cancer (PCa) treated with curative intent, controversy exists regarding the impact of biochemical recurrence (BCR) on oncological outcomes.
T. Van den Broeck, R. V. D. van den Bergh, N. Arfi, T. Gross, L. Moris, E. Briers, M. Cumberbatch, M. De Santis, D. Tilki, S. Fanti, N. Fossati, S. Gillessen, J. Grummet, A. Henry, M. Lardas, M. Liew, O. Rouvière, J. Pecanka, M. Mason, I. Schoots, T. van der Kwast, H. G. van der Poel, T. Wiegel, P. Willemse, Yuhong Yuan, T. Lam, P. Cornford, N. Mottet   +27 more
semanticscholar   +1 more source

Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence

Journal of Nuclear Medicine, 2020
Prostate-specific membrane antigen (PSMA)–ligand PET/CT is performed on patients with prostate cancer to stage the disease initially or to identify sites of recurrence after definitive therapy.
K. Sprute, V. Kramer, S. Koerber, M. Meneses, R. Fernández, C. Soza-Ried, Mathias Eiber, W. Weber, I. Rauscher, K. Rahbar, M. Schaefers, T. Watabe, M. Uemura, Sadahiro Naka, N. Nonomura, J. Hatazawa, C. Schwab, V. Schütz, M. Hohenfellner, T. Holland-Letz, J. Debus, C. Kratochwil, H. Amaral, P. Choyke, U. Haberkorn, C. Sandoval, F. Giesel   +26 more
semanticscholar   +1 more source

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Radiation Oncology, 2018
Background PSMA PET/CT visualises prostate cancer residual disease or recurrence at lower PSA levels compared to conventional imaging and results in a change of treatment in a remarkable high number of patients.
Nina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan, Annika Herlemann, Alexander Buchner, Christian Stief, Chukwuka Eze, Paul Rogowski, Minglun Li, Peter Bartenstein, Ute Ganswindt, Claus Belka   +11 more
doaj   +1 more source

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence

Frontiers in Endocrinology, 2022
Prostate cancer (PCa) induced death is the predominant cause of cancer-related death among men in 48 countries. After radical treatment, biochemical recurrence has become an important factor for prognosis.
Jie Jiang, Xiaoxia Tang, Yongzhu Pu, Yong Yang, Conghui Yang, Fake Yang, Yadong Tian, Jindan Li, Hua Sun, Sheng Zhao, Long Chen   +10 more
doaj   +1 more source

18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.

The Lancet Oncology, 2019
BACKGROUND National Comprehensive Cancer Network guidelines consider 18F-fluciclovine PET-CT for prostate cancer biochemical recurrence localisation after radical prostatectomy, whereas European Association of Urology guidelines recommend prostate ...
J. Calais, F. Ceci, M. Eiber, T. Hope, M. Hofman, C. Rischpler, T. Bach‐Gansmo, C. Nanni, B. Savir-Baruch, D. Elashoff, T. Grogan, Magnus Dahlbom, R. Slavik, J. Gartmann, K. Nguyen, V. Lok, H. Jadvar, A. Kishan, M. Rettig, R. Reiter, W. Fendler, J. Czernin   +21 more
semanticscholar   +1 more source

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy

Prostate International, 2016
Background: The Gleason grading system is a powerful predictor of prostate cancer (PCa) prognosis. Gleason scores (GS) of 8–10 are considered as a single high-risk grade category, and Gleason Pattern 5 (GP5) predicts biochemical recurrence. We report the
Tomoyuki Makino, Sotaro Miwa, Kiyoshi Koshida   +2 more
doaj   +1 more source

Predictive Role of De Ritis Ratio in Biochemical Recurrence After Radical Prostatectomy

Haseki Tıp Bülteni, 2020
Aim:To analyze the role of De Ritis (aspartate aminotransferase/alanine aminotransferase) ratio in predicting biochemical recurrence (BCR) after radical prostatectomy (RP).Methods:We retrospectively evaluated 425 patients with localised prostate cancer ...
Kaan Karamık, Yasin Aktaş, Ali Yıldız, İbrahim Erol, Ekrem İslamoğlu, Mutlu Ateş, Taha Ölçücü, Kayhan Yılmaz, Murat Savaş   +8 more
doaj   +1 more source